Biosimilar ABP 654 Has Functional Similarity to Ustekinumab (Stelara ®)
Study finds the biosimilar ABP 654 and ustekinumab do not have clinical meaningful differences according to the step-wide totality-of-evidence approach and thus have similar psychochemical and biological properties.
Source: hcplive.com